Use of Geriatric Screening Tools to Assess Older Patients With Cancer
A review of geriatric assessment tools and their role in assessing older patients with cancer before and after treatment.
Geriatrics
Study Shows Bivalent RSV Vaccine Candidate Provides Protection for Older Adults
The RSVpreF vaccine candidate consists of 2 prefusion F proteins selected to optimize protection against RSV A and B.
Caution Urged About Ageism in Patient Care
Clinicians need to be aware of their assumptions about patients based on age.
Time to Benefit After Intensive Blood Pressure Reduction in Older Adults
Patients’ life expectancy should be considered when deciding whether to intensify hypertension treatment, according to investigators.
Reductions in Amyloid Beta Plaques, P-Tau Seen With Aducanumab Over 2 Years Later
The long-term extension phase of the phase 3 EMERGE and ENGAGE trials evaluated the efficacy and safety of aducanumab-avwa in adults aged 50 to 85 years with early Alzheimer disease.
Donepezil Transdermal Patch Approved for Alzheimer Disease
Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion.
Increased Dairy Intake Reduces Falls in Older Adults in Residential Care
Foods rich in calcium and protein like milk, yogurt, and cheese slow bone loss and improve insulin-like growth factor 1, which promotes bone and tissue growth. Researchers studied whether adding these to the diets of people aged 80 and older at care facilities would decrease their risk of hip fractures and falls.
FDA Approves First Eye Drop to Treat Presbyopia
The approval was based on data from the phase 3 GEMINI 1 and GEMINI 2 studies that evaluated Vuity in a total of 750 patients aged 40 to 55 years with presbyopia.
Study Shows Loneliness Tied to Use of High-Risk Medications
The study authors utilized the National Social Life, Health, and Aging Project leave-behind questionnaire to obtain data on a total of 6017 adults over 65 years of age.
Stem Cell Therapy Gets Fast Track Status for Parkinson Disease
DA01 is an investigational pluripotent stem cell-derived dopaminergic neuron therapy designed to replace the midbrian dopaminergic neurons lost in Parkinson disease.
- Loading...
Loading...
Next post in News
Loading... 
Loading...